Helping anti-cancer activity of cetuximab (Erbitux) by monoclonal antibody conjugated nanocurcumin - In vitro studies on human oral squamous carcinoma cell line (OECM)
Saved in:
Main Authors: | Rethinam Senthil, S. Raghunandhakumar |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-03-01
|
Series: | Oral Oncology Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2772906024000967 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Inhibitory potential against oral squamous cancer cells demonstrated by amyloid beta peptide (s)/doxorubicin (DOX) conjugates
by: Rethinam Senthil
Published: (2024-06-01) -
STUDY OF VEGF-A AND TGF-Β LEVELS IN BIOPTATES OF SQUAMOUS CELL CARCINOMA OF THE TONGUE AND MOUTH FLOOR MUCOSA IN POLYCHEMOTHERAPY WITH MONOCLONAL ANTIBODIES – CETUXIMAB
by: O. I. Kit, et al.
Published: (2019-09-01) -
Conjugation of Daunorubicin to Monoclonal Antihuman Sarcoma Antibody by a Novel Method
by: Michel Pagé, et al.
Published: (1992-01-01) -
Ruthenium (Ru) complex conjugates drugs and targeted tumors by inhibiting oral cancer cells
by: Rethinam Senthil
Published: (2024-06-01) -
Reduced-graphene oxide (R-GO) conjugated methotrexate (MTX) killing of oral cancer cells
by: Rethinam Senthil
Published: (2024-06-01)